Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina N Hoba

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Communications Chemistry|February 3, 2025
A microscale thermophoresis-based enzymatic RNA methyltransferase assay enables the discovery of DNMT2 inhibitorsZarina Nidoieva, Mark O Sabin, Tristan Dewald, et al.
Biosensors & Bioelectronics|November 12, 2023
Protease detection in the biosensor era: A reviewPratika Rai, Sabrina N Hoba, Celine Buchmann, et al.
RSC Medicinal Chemistry|September 8, 2025
Parallel synthesis of 5'-amino-5'-deoxy-adenosine derivatives for focused chemical space exploration and their application as methyltransferase inhibitorsSabrina N Hoba, Marvin Schwickert, Luis Kammerer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 14, 2023
Next Generation of Fluorometric Protease Assays: 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-amides (NBD-Amides) as Class-Spanning Protease SubstratesHannah Maus, Patrick Müller, Mergim Meta, et al.
Journal of Medicinal Chemistry|April 7, 2025
Electrostatic Anchoring in RNA-Ligand Design─Dissecting the Effects of Positive Charges on Affinity, Selectivity, Binding Kinetics, and ThermodynamicsLaura Almena Rodriguez, Elisabeth Kallert, Jan-Åke Husmann, et al.
Angewandte Chemie (International Ed. in English)|August 15, 2024
Nanomole Scale Screening of Fluorescent RNA-Methyltransferase Probes Enables the Discovery of METTL1 InhibitorsJ Laurenz Meidner, Ariane F Frey, Robert A Zimmermann, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Covalent <i>S</i>-Adenosylhomocysteine-Based DNA Methyltransferase 2 Inhibitors with a New Type of Aryl WarheadMarvin Schwickert, Robert A Zimmermann, Tanja Habeck, et al.
Journal of Medicinal Chemistry|July 18, 2022
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer TreatmentMarvin Schwickert, Tim R Fischer, Robert A Zimmermann, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Communications Chemistry|February 3, 2025
A microscale thermophoresis-based enzymatic RNA methyltransferase assay enables the discovery of DNMT2 inhibitorsZarina Nidoieva, Mark O Sabin, Tristan Dewald, et al.
Biosensors & Bioelectronics|November 12, 2023
Protease detection in the biosensor era: A reviewPratika Rai, Sabrina N Hoba, Celine Buchmann, et al.
RSC Medicinal Chemistry|September 8, 2025
Parallel synthesis of 5'-amino-5'-deoxy-adenosine derivatives for focused chemical space exploration and their application as methyltransferase inhibitorsSabrina N Hoba, Marvin Schwickert, Luis Kammerer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 14, 2023
Next Generation of Fluorometric Protease Assays: 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-amides (NBD-Amides) as Class-Spanning Protease SubstratesHannah Maus, Patrick Müller, Mergim Meta, et al.
Journal of Medicinal Chemistry|April 7, 2025
Electrostatic Anchoring in RNA-Ligand Design─Dissecting the Effects of Positive Charges on Affinity, Selectivity, Binding Kinetics, and ThermodynamicsLaura Almena Rodriguez, Elisabeth Kallert, Jan-Åke Husmann, et al.
Angewandte Chemie (International Ed. in English)|August 15, 2024
Nanomole Scale Screening of Fluorescent RNA-Methyltransferase Probes Enables the Discovery of METTL1 InhibitorsJ Laurenz Meidner, Ariane F Frey, Robert A Zimmermann, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Covalent <i>S</i>-Adenosylhomocysteine-Based DNA Methyltransferase 2 Inhibitors with a New Type of Aryl WarheadMarvin Schwickert, Robert A Zimmermann, Tanja Habeck, et al.
Journal of Medicinal Chemistry|July 18, 2022
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer TreatmentMarvin Schwickert, Tim R Fischer, Robert A Zimmermann, et al.
Pageof 1